Immune-Pineal Axis Function in Chronic Tension-Type Headache
1 other identifier
interventional
34
1 country
1
Brief Summary
The purpose of this study is to determine whether electroacupuncture is effective in the treatment of chronic tension-type headache, measured by Headache Impact Test, Visual Analogue Scale and biomarkers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Oct 2010
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
September 15, 2013
CompletedFirst Posted
Study publicly available on registry
October 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedNovember 18, 2013
September 1, 2013
3 years
September 15, 2013
November 15, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Visual Analogue Scale (VAS)
The intensity of pain was measured by a 10 cm VAS. The scores range from no pain (zero) to the worst possible pain (10 cm).
An expected average of 3 months. (At baseline and at the end of each intervention period).
Secondary Outcomes (1)
Headache Impact Test (HIT-6)
An expected average of 3 months. (At baseline and at the end of each intervention period).
Other Outcomes (1)
Biomarkers (BDNF nd TNF)
An expected average of 3 months. (At baseline and at the end of each intervention period).
Study Arms (2)
Electroacupuncture
EXPERIMENTALAll patients will receive 10 electroacupuncture sessions.
Placebo Sham
SHAM COMPARATORAll patients will receive 10 placebo sham sessions.
Interventions
Eletroacupuncture performed using acupuncture needles.
Placebo Sham is performed using electrodes, without electrical stimulation. Lights and sounds were identical to active treatment.
Eligibility Criteria
You may qualify if:
- Women,
- Aged between 18 and 60 years old,
- Providing informed consent to participate in the study,
- Literate,
- Clinical diagnosis of Chronic Tension-Type Headache according to the International Headache Society.
You may not qualify if:
- Psychiatric or neurologic disorder that unable patient to consent and follow study protocol,
- De-compensated systemic disease,
- Chronic inflammatory disease (e.g. Systemic Lupus Erythematous, Rheumatoid Arthritis),
- HIV.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital de Clinicas e Porto Alegre (HCPA)
Porto Alegre, Rio Grande do Sul, 90035-003, Brazil
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Wolnei Caumo, MD, PhD
Hospital de Clinicas de Porto Alegre
- PRINCIPAL INVESTIGATOR
Mônica Chassot
Federal University of Health Science of Porto Alegre
- PRINCIPAL INVESTIGATOR
Francislea C. Sehn
Federal University of Health Science of Porto Alegre
- PRINCIPAL INVESTIGATOR
Rafael Vercelino
Federal University of Health Science of Porto Alegre
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, Professor and coordinator of Pain & Neuromodulation Lab
Study Record Dates
First Submitted
September 15, 2013
First Posted
October 1, 2013
Study Start
October 1, 2010
Primary Completion
October 1, 2013
Study Completion
November 1, 2013
Last Updated
November 18, 2013
Record last verified: 2013-09